Atara Biotherapeutics Inc... (ATRA)
NASDAQ: ATRA
· Real-Time Price · USD
12.24
0.52 (4.44%)
At close: Aug 15, 2025, 3:59 PM
12.74
4.08%
After-hours: Aug 15, 2025, 07:47 PM EDT
Atara Biotherapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 5.79M | -15.64M | -85.4M | -133.16M | -181.05M | -233.11M | -276.13M | -290.25M | -304.54M | -214.97M | -228.3M | -247.08M | -247.65M | -349.91M | -340.14M | -328.1M | -317.78M | -311.45M |
Depreciation & Amortization | 4.59M | 5.42M | 5.02M | 5.13M | 5.13M | 5.01M | 4.83M | 4.88M | 5.04M | 5.28M | 5.65M | 6.89M | 7.83M | 8.71M | 9.35M | 9.01M | 8.87M | 8.61M |
Stock-Based Compensation | 19.28M | 22.81M | 27M | 31.08M | 35.8M | 42.02M | 45.39M | 46.82M | 49.7M | 51.27M | 53.84M | 56.5M | 56.24M | 55.93M | 53.87M | 51.34M | 50.83M | 50.98M |
Other Working Capital | -20.51M | -139.43M | -59.84M | -2.92M | -8.84M | 32.31M | 20.48M | 36.03M | 39.83M | -15.8M | -10.38M | -14.11M | -11.5M | 38.18M | 45.77M | 66.36M | 67.12M | 75.01M |
Other Non-Cash Items | -77.73M | 21.5M | 35.73M | 90.45M | 91.05M | 91.15M | 70.77M | 15.31M | 13.91M | 12.45M | 9.77M | 7.53M | 5.14M | 2.77M | 2.04M | 1.72M | 1.56M | 1.55M |
Deferred Income Tax | n/a | n/a | n/a | -52.21M | -52.42M | -53.18M | -53.18M | -969K | -755K | n/a | n/a | 539K | 939K | 1.43M | 1.79M | 1.66M | 1.55M | 1.28M |
Change in Working Capital | -15.84M | -101.34M | -30.96M | -15.83M | -20.42M | -15.94M | 15.34M | 24.75M | 23.49M | -28.43M | -61.47M | -22.27M | -14.31M | 41.71M | 52.58M | 74M | 70.62M | 69.63M |
Operating Cash Flow | -63.92M | -67.24M | -68.72M | -94.65M | -142.01M | -184.16M | -192.98M | -199.45M | -213.16M | -224.33M | -270.43M | -247.82M | -241.74M | -239.35M | -220.52M | -190.37M | -184.35M | -179.41M |
Capital Expenditures | -90K | -119K | -246K | -200K | -481K | -951K | -1.22M | -1.22M | -1.07M | -1.99M | -4.19M | -6.62M | -10.35M | -10.99M | -10.58M | -8.71M | -5.36M | -5.38M |
Cash Acquisitions | n/a | n/a | n/a | -40.36M | -40.33M | -90.31M | -84.71M | -95.6M | -155.46M | -10.71M | -16.32M | 34.94M | 94.77M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -25.08M | -19.66M | -19.66M | -19.67M | -26K | -15.77M | -83.67M | -83.1M | -99.15M | -222.06M | -180.59M | -257.54M | -307.35M | -233.5M | -301.13M | -371.43M | -356.51M | -463.07M |
Sales Maturities Of Investments | 23.66M | 30.89M | 28.54M | 35.06M | 102.76M | 161.26M | 208.71M | 249.4M | 254.6M | 266.02M | 292.97M | 296.81M | 291.84M | 313.46M | 333.97M | 389.83M | 377.93M | 322.25M |
Other Investing Acitivies | 349K | n/a | 14.84M | 55.2M | 55.23M | 105.21M | 84.76M | 95.65M | 155.46M | 138.72M | 207.15M | 134.04M | 79.26M | 79.96M | 32.84M | 18.41M | 21.42M | -140.82M |
Investing Cash Flow | -1.16M | 11.11M | 8.62M | 15.19M | 102.3M | 144.59M | 123.87M | 165.14M | 154.39M | 136.73M | 202.96M | 127.41M | 68.91M | 68.97M | 22.26M | 9.69M | 16.06M | -146.2M |
Debt Repayment | -682K | -915K | -892K | -872K | -883K | -862K | -947K | -854K | -852K | -766K | -518K | -458K | -314K | -252K | -254K | -292K | -322K | -365K |
Common Stock Repurchased | 6K | 6K | 6K | 6K | n/a | -1K | -1K | -1K | -5K | -7K | -7K | -7K | -3K | -13K | -13K | -13K | -13K | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 75.37M | 60.18M | 60.17M | -14.54M | 287K | 859K | 772K | 1.02M | 1.01M | 1.62M | 1.09M | 2.23M | 3.08M | 4.31M | 5.44M | 7.14M | 6.34M | 5.72M |
Financial Cash Flow | 50.52M | 34.89M | 59.28M | 61.12M | 25.12M | 25.92M | 2.01M | 32.79M | 32.78M | 33.47M | 53.08M | 72.26M | 119.61M | 120.9M | 103.94M | 231.27M | 217.64M | 406.51M |
Net Cash Flow | -14.56M | -21.25M | -811K | -18.34M | -14.58M | -13.65M | -67.1M | -1.52M | -25.99M | -54.13M | -14.39M | -48.14M | -53.22M | -49.48M | -94.32M | 50.59M | 49.34M | 80.89M |
Free Cash Flow | -64.01M | -67.36M | -68.96M | -94.85M | -142.49M | -185.11M | -194.2M | -200.67M | -214.23M | -226.32M | -274.62M | -254.44M | -252.09M | -250.34M | -231.1M | -199.09M | -189.72M | -184.79M |